作者

David Mulder

高级律师

Read More

Christian Dekoninck

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr Paul England

高级专业支持律师

Read More
作者

David Mulder

高级律师

Read More

Christian Dekoninck

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr Paul England

高级专业支持律师

Read More

2020年11月9日

Pharmaceutical patent law – 1 / 2 观点

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

UPC

It is time to think about UPC opt-out again: how it is achieved and its strategic implications

Part 2

2022年1月17日
In-depth analysis

作者

点击此处了解更多
UPC

It is time to think about UPC opt-out again: what opt-out does

Part 1

2022年1月17日
In-depth analysis

作者

点击此处了解更多
专利与创新

Taylor Wessing announces a major Unified Patent Court publishing project

2021年11月22日
Quick read

作者

点击此处了解更多